Tenaya Therapeutics (TNYA) Total Current Liabilities (2020 - 2026)

Tenaya Therapeutics' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $16.8 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 18.58% year-over-year to $16.8 million; the TTM figure through Mar 2026 stood at $16.8 million (up 18.58% YoY), while the FY2025 annual figure was $15.4 million, down 3.37% from the prior year.
• Total Current Liabilities was $16.8 million for Q1 2026 at Tenaya Therapeutics, up from $15.4 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $24.2 million in Q4 2022 to a low of $12.7 million in Q2 2025.
• Historically, Total Current Liabilities has averaged $17.8 million across 5 years, with a median of $17.7 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 91.23% in 2022, then retreated 29.73% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $24.2 million in 2022, then retreated by 6.25% to $22.7 million in 2023, then declined by 29.73% to $16.0 million in 2024, then slipped by 3.37% to $15.4 million in 2025, then climbed by 8.71% to $16.8 million in 2026.
• The last three Total Current Liabilities figures came in at $16.8 million (Q1 2026), $15.4 million (Q4 2025), and $13.2 million (Q3 2025), per Business Quant data.